<DOC>
	<DOCNO>NCT02156882</DOCNO>
	<brief_summary>In longitudinal study follow time least 6 month , 300 tuberculosis ( TB ) patient TB suspect screen TB use Xpert MTB/RIF assay along standard smear microscopy Ziehl-Neelsen stain TB health clinic locate Mavalane health center . Confirmed TB case follow TB therapy month six treatment initiation order obtain clinical microbiological data treatment include treatment response . Apart relevant research question field TB diagnostics treatment , main objective study development clinical TB research site , include capacity development clinical laboratory base TB research method , Mavalane , Maputo .</brief_summary>
	<brief_title>Establishment Clinical Trial Unit Mavalane , Maputo , Mozambique</brief_title>
	<detailed_description>Main study objective : To assess feasibility perform TB clinical trial Maputo , Mozambique , screening , examine , enrollment , follow-up data collection TB patient send TB treatment well TB suspect send smear microscopy TB clinic Mavalane health center . Screening study patient : After consent , study participant ( confirm suspect TB ) screen TB smear microscopy Ziehl-Neelsen staining Xpert MTB/RIF assay . In patient sign extrapulmonary TB manifestation , specimen collection sputum decide treat physician patient ' best interest , establish TB diagnosis use smear microscopy and/or Xpert MTB/RIF assay . Patients without positive Xpert MTB/RIF-assay result continue study refer National TB Program evaluation treatment . In patient positive Xpert MTB/RIF result specimen anti TB treatment commence accord National Guidelines . All TB positive study participant follow 6 month TB treatment initiation . Study method : Follow visit occur week 1 , 2 , 4 , 8 , 12 , 17 26 commencement TB therapy . An optional visit perform select patient week 52 order confirm cure TB disease . At study visit , clinical investigation perform medical questionnaire complete participant . Further , sputum urine sample collect evaluation new TB diagnostics . A chest x-ray perform blood HIV testing , CD4 count , biochemistry full blood picture collect baseline medically indicate course study . Data record analysis : The study follow ethical principle outline declaration Helsinki revision ( last 2008 ) perform compliance guideline Good Clinical , Laboratory ( GCLP ) Clinical Data Management Practice ( GCDMP ) . All essential document archive 3 year . All patient information treat strictly confidential manner link unique ID number personal identifier . Data collect paper CRFs , enter secured clinical data management system , daily backups do . Double data entry minimize data entry error , full data validation cleaning process employ .</detailed_description>
	<mesh_term>Tuberculosis</mesh_term>
	<criteria>&gt; /= 18 year old Able willing give inform consent study participation , include HIVtesting Positive TB result Xpert MTB/RIF perform study clinic TB treatment last 6 month Abandoned TB treatment time point past Suffering condition likely lead uncooperative behaviour e.g . psychiatric illness alcoholism . Karnofsky index 50 %</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>TB</keyword>
	<keyword>Tuberculosis</keyword>
	<keyword>MaTuTU - Maputo Tuberculosis Trial Unit</keyword>
	<keyword>Clinical Trial Capacity Development</keyword>
</DOC>